{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:30:20Z","timestamp":1789122620450,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1038\/s41431-024-01674-z","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T02:03:45Z","timestamp":1723082625000},"page":"1474-1482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Late-onset tumors in rhabdoid tumor predisposition syndrome type-1 (RTPS1) and implications for surveillance"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5394-8194","authenticated-orcid":false,"given":"Yoshiko","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryl","family":"Acker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Druker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalene","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Stephen","family":"Meyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6063-7562","authenticated-orcid":false,"given":"Rosemarie E.","family":"Venier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Goudie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Stosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Louise C.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-9763","authenticated-orcid":false,"given":"David","family":"Malkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3283-2197","authenticated-orcid":false,"given":"Anita","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0039-3652","authenticated-orcid":false,"given":"Bailey","family":"Gallinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"1674_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/1093526617749671","volume":"21","author":"BR Pawel","year":"2018","unstructured":"Pawel BR. SMARCB1-deficient Tumors of Childhood: A Practical Guide. Pediatr Dev Pathol. 2018;21:6\u201328.","journal-title":"Pediatr Dev Pathol"},{"key":"1674_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.semdp.2020.05.005","volume":"38","author":"I-M Schaefer","year":"2021","unstructured":"Schaefer I-M, Hornick JL. SWI\/SNF complex-deficient soft tissue neoplasms: An update. Semin Diagn Pathol. 2021;38:222\u201331.","journal-title":"Semin Diagn Pathol"},{"key":"1674_CR3","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1038\/s41379-022-01148-x","volume":"35","author":"JK Dermawan","year":"2022","unstructured":"Dermawan JK, Singer S, Tap WD, Nacev BA, Chi P, Wexler LH, et al. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms. Mod Pathol. 2022;35:1900\u20139.","journal-title":"Mod Pathol"},{"key":"1674_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/bpa.12413","volume":"27","author":"PD Johann","year":"2017","unstructured":"Johann PD, Hovestadt V, Thomas C, Jeibmann A, He\u00df K, Bens S, et al. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome. Brain Pathol. 2017;27:411\u20138.","journal-title":"Brain Pathol"},{"key":"1674_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00401-019-02094-w","volume":"139","author":"C Thomas","year":"2020","unstructured":"Thomas C, Wefers A, Bens S, Nemes K, Agaimy A, Oyen F, et al. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults. Acta Neuropathol. 2020;139:277\u201386.","journal-title":"Acta Neuropathol"},{"key":"1674_CR6","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41379-022-01127-2","volume":"35","author":"Z Duan","year":"2022","unstructured":"Duan Z, Yao K, Yang S, Qu Y, Ren M, Zhang Y, et al. Primary adult sellar SMARCB1\/INI1-deficient tumor represents a subtype of atypical teratoid\/rhabdoid tumor. Mod Pathol. 2022;35:1910\u201320.","journal-title":"Mod Pathol"},{"key":"1674_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"1674_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cancergen.2014.04.001","volume":"207","author":"MJ Smith","year":"2014","unstructured":"Smith MJ, Wallace AJ, Bowers NL, Eaton H, Evans DGR. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. Cancer Genet. 2014;207:373\u20138.","journal-title":"Cancer Genet"},{"key":"1674_CR9","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1158\/1078-0432.CCR-17-0590","volume":"23","author":"DGR Evans","year":"2017","unstructured":"Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Druker H, et al. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders. Clin Cancer Res. 2017;23:e54\u201361.","journal-title":"Clin Cancer Res"},{"key":"1674_CR10","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1158\/1078-0432.CCR-17-0595","volume":"23","author":"WD Foulkes","year":"2017","unstructured":"Foulkes WD, Kamihara J, Evans DGR, Brugi\u00e8res L, Bourdeaut F, Molenaar JJ, et al. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome. Clin Cancer Res. 2017;23:e62\u20137.","journal-title":"Clin Cancer Res"},{"key":"1674_CR11","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet Med. 2022;24:1967\u201377.","journal-title":"Genet Med"},{"key":"1674_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.586288","volume":"11","author":"G Del Baldo","year":"2021","unstructured":"Del Baldo G, Carta R, Alessi I, Merli P, Agolini E, Rinelli M, et al. Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management. Front Oncol. 2021;11:586288.","journal-title":"Front Oncol"},{"key":"1674_CR13","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/S1470-2045(13)70088-3","volume":"14","author":"B Brennan","year":"2013","unstructured":"Brennan B, Stiller C, Bourdeaut F. Extracranial rhabdoid tumours: what we have learned so far and future directions. Lancet Oncol. 2013;14:e329\u201336.","journal-title":"Lancet Oncol"},{"key":"1674_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10689-021-00229-1","volume":"20","author":"MC Fr\u00fchwald","year":"2021","unstructured":"Fr\u00fchwald MC, Nemes K, Boztug H, Cornips MCA, Evans DG, Farah R, et al. Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group. Fam Cancer. 2021;20:305\u201316.","journal-title":"Fam Cancer"},{"key":"1674_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2147\/CMAR.S289544","volume":"14","author":"K Nemes","year":"2022","unstructured":"Nemes K, Johann PD, T\u00fcchert S, Melchior P, Vokuhl C, Siebert R, et al. Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors. Cancer Manag Res. 2022;14:479\u201398.","journal-title":"Cancer Manag Res"},{"key":"1674_CR16","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41431-018-0143-1","volume":"26","author":"T Holsten","year":"2018","unstructured":"Holsten T, Bens S, Oyen F, Nemes K, Hasselblatt M, Kordes U, et al. Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis. Eur J Hum Genet. 2018;26:1083\u201393.","journal-title":"Eur J Hum Genet"},{"key":"1674_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/neuros\/nyab021","volume":"88","author":"SM Belakhoua","year":"2021","unstructured":"Belakhoua SM, Rodriguez FJ. Diagnostic Pathology of Tumors of Peripheral Nerve. Neurosurgery. 2021;88:443\u201356.","journal-title":"Neurosurgery"},{"key":"1674_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/pbc.22831","volume":"56","author":"KW Eaton","year":"2011","unstructured":"Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA. Spectrum of SMARCB1\/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56:7\u201315.","journal-title":"Pediatr Blood Cancer"},{"key":"1674_CR19","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1200\/JCO.19.01776","volume":"38","author":"AT Reddy","year":"2020","unstructured":"Reddy AT, Strother DR, Judkins AR, Burger PC, Pollack IF, Krailo MD, et al. Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid\/Rhabdoid Tumor: A Report From the Children\u2019s Oncology Group Trial ACNS0333. J Clin Oncol. 2020;38:1175\u201385.","journal-title":"J Clin Oncol"},{"key":"1674_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"P Harris","year":"2009","unstructured":"Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377\u201381.","journal-title":"J Biomed Inf"},{"key":"1674_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27546","volume":"66","author":"MD Bhatt","year":"2019","unstructured":"Bhatt MD, Al-Karmi S, Druker H, Gupta A, Lu M, Malkin D, et al. Second rhabdoid tumor 8 years after treatment of atypical teratoid\/rhabdoid tumor in a child with germline SMARCB1 mutation. Pediatr Blood Cancer. 2019;66:e27546.","journal-title":"Pediatr Blood Cancer"},{"key":"1674_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/1078-0432.CCR-10-1795","volume":"17","author":"F Bourdeaut","year":"2011","unstructured":"Bourdeaut F, Lequin D, Brugi\u00e8res L, Reynaud S, Dufour C, Doz F, et al. Frequent hSNF5\/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res. 2011;17:31\u20138.","journal-title":"Clin Cancer Res"},{"key":"1674_CR23","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s41431-020-0614-z","volume":"28","author":"R Shirai","year":"2020","unstructured":"Shirai R, Osumi T, Terashima K, Kiyotani C, Uchiyama M, Tsujimoto S, et al. High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors. Eur J Hum Genet. 2020;28:1124\u20138.","journal-title":"Eur J Hum Genet"},{"key":"1674_CR24","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1097\/PAS.0b013e31826cbe7a","volume":"36","author":"F Forest","year":"2012","unstructured":"Forest F, David A, Arrufat S, Pierron G, Ranchere-Vince D, Stephan J-L, et al. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations. Am J Surg Pathol. 2012;36:1892\u20136.","journal-title":"Am J Surg Pathol"},{"key":"1674_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/1093526620986492","volume":"24","author":"TG Baker","year":"2021","unstructured":"Baker TG, Lyons MJ, Leddy L, Parham DM, Welsh CT. Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid\/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome. Pediatr Dev Pathol. 2021;24:164\u20138.","journal-title":"Pediatr Dev Pathol"},{"key":"1674_CR26","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1086\/302639","volume":"65","author":"N S\u00e9venet","year":"1999","unstructured":"S\u00e9venet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Constitutional mutations of the hSNF5\/INI1 gene predispose to a variety of cancers. Am J Hum Genet. 1999;65:1342\u20138.","journal-title":"Am J Hum Genet"},{"key":"1674_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/pin.13056","volume":"71","author":"H Fukushima","year":"2021","unstructured":"Fukushima H, Yamasaki K, Sakaida M, Tsujio N, Okuno T, Ishii N, et al. Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor. Pathol Int. 2021;71:155\u201360.","journal-title":"Pathol Int"},{"key":"1674_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cancergen.2014.05.007","volume":"207","author":"KR Bosse","year":"2014","unstructured":"Bosse KR, Shukla AR, Pawel B, Chikwava KR, Santi M, Tooke L, et al. Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion. Cancer Genet. 2014;207:415\u20139.","journal-title":"Cancer Genet"},{"key":"1674_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/jmg.2008.060152","volume":"46","author":"JJ Swensen","year":"2009","unstructured":"Swensen JJ, Keyser J, Coffin CM, Biegel JA, Viskochil DH, Williams MS. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet. 2009;46:68\u201372.","journal-title":"J Med Genet"},{"key":"1674_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ejmg.2010.12.007","volume":"54","author":"RA Beddow","year":"2011","unstructured":"Beddow RA, Smith M, Kidd A, Corbett R, Hunter AG. Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid\/rhabdoid tumour. Eur J Med Genet. 2011;54:295\u20138.","journal-title":"Eur J Med Genet"},{"key":"1674_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/mgg3.412","volume":"6","author":"H Kehrer-Sawatzki","year":"2018","unstructured":"Kehrer-Sawatzki H, Kordes U, Seiffert S, Summerer A, Hagel C, Sch\u00fcller U, et al. Co-occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1. Mol Genet Genom Med. 2018;6:627\u201337.","journal-title":"Mol Genet Genom Med"},{"key":"1674_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/sj.bjc.6604156","volume":"98","author":"ACJ Ammerlaan","year":"2008","unstructured":"Ammerlaan ACJ, Ararou A, Houben MPWA, Baas F, Tijssen CC, Teepen JLJM, et al. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Br J Cancer. 2008;98:474\u20139.","journal-title":"Br J Cancer"},{"key":"1674_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/PAS.0b013e3182380802","volume":"36","author":"JM Carter","year":"2012","unstructured":"Carter JM, O\u2019Hara C, Dundas G, Gilchrist D, Collins MS, Eaton K, et al. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with \u201cneuroblastoma-like\u201d schwannomatosis and a novel germline SMARCB1 mutation. Am J Surg Pathol. 2012;36:154\u201360.","journal-title":"Am J Surg Pathol"},{"key":"1674_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27030","volume":"65","author":"SA Upadhyaya","year":"2018","unstructured":"Upadhyaya SA, McGee RB, Wilky BA, Broniscer A. Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer. 2018;65:e27030.","journal-title":"Pediatr Blood Cancer"},{"key":"1674_CR35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.wneu.2019.04.083","volume":"127","author":"MR Voisin","year":"2019","unstructured":"Voisin MR, Ovenden C, Tsang DS, Gupta AA, Huang A, Gao AF, et al. Atypical Teratoid\/Rhabdoid Sellar Tumor in an Adult with a Familial History of a Germline SMARCB1 Mutation: Case Report and Review of the Literature. World Neurosurg. 2019;127:336\u201345.","journal-title":"World Neurosurg"},{"key":"1674_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00431-010-1377-2","volume":"170","author":"A Teplick","year":"2011","unstructured":"Teplick A, Kowalski M, Biegel JA, Nichols KE. Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician. Eur J Pediatr. 2011;170:285\u201394.","journal-title":"Eur J Pediatr"},{"key":"1674_CR37","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1158\/1078-0432.CCR-17-2026","volume":"23","author":"D Malkin","year":"2017","unstructured":"Malkin D, Nichols KE, Schiffman JD, Plon SE, Brodeur GM. The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking Glass. Clin Cancer Res. 2017;23:e133\u20137.","journal-title":"Clin Cancer Res"},{"key":"1674_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00247-021-05023-w","volume":"52","author":"H Al-Sarhani","year":"2022","unstructured":"Al-Sarhani H, Gottumukkala RV, Grasparil ADS 2nd, Tung EL, Gee MS, et al. Screening of cancer predisposition syndromes. Pediatr Radio. 2022;52:401\u201317.","journal-title":"Pediatr Radio"},{"key":"1674_CR39","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41431-022-01086-x","volume":"30","author":"DG Evans","year":"2022","unstructured":"Evans DG, Mostaccioli S, Pang D, Fadzil O Connor M, Pittara M, Champollion N, et al. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis. Eur J Hum Genet. 2022;30:812\u20137.","journal-title":"Eur J Hum Genet"},{"key":"1674_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00439-016-1753-8","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki H, Farschtschi S, Mautner V-F, Cooper DN. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis. Hum Genet. 2017;136:129\u201348.","journal-title":"Hum Genet"},{"key":"1674_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejmg.2012.09.009","volume":"56","author":"CR Fagerberg","year":"2013","unstructured":"Fagerberg CR, Graakjaer J, Heinl UD, Ousager LB, Dreyer I, Kirchhoff M, et al. Heart defects and other features of the 22q11 distal deletion syndrome. Eur J Med Genet. 2013;56:98\u2013107.","journal-title":"Eur J Med Genet"},{"key":"1674_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00439-007-0386-3","volume":"122","author":"EM Jackson","year":"2007","unstructured":"Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, Nikkel SM, et al. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum Genet. 2007;122:117\u201327.","journal-title":"Hum Genet"},{"key":"1674_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ajhg.2007.09.014","volume":"82","author":"S Ben-Shachar","year":"2008","unstructured":"Ben-Shachar S, Ou Z, Shaw CA, Belmont JW, Patel MS, Hummel M, et al. 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am J Hum Genet. 2008;82:214\u201321.","journal-title":"Am J Hum Genet"},{"key":"1674_CR44","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/ajmg.a.35517","volume":"158A","author":"JMA Verhagen","year":"2012","unstructured":"Verhagen JMA, Diderich KEM, Oudesluijs G, Mancini GMS, Eggink AJ, Verkleij-Hagoort AC, et al. Phenotypic variability of atypical 22q11.2 deletions not including TBX1. Am J Med Genet A. 2012;158A:2412\u201320.","journal-title":"Am J Med Genet A"},{"key":"1674_CR45","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1750-3639.1997.tb00902.x","volume":"7","author":"A Rubio","year":"1997","unstructured":"Rubio A. March 1997\u20134 year old girl with ring chromosome 22 and brain tumor. Brain Pathol. 1997;7:1027\u20138.","journal-title":"Brain Pathol"},{"key":"1674_CR46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s10014-022-00440-7","volume":"39","author":"H Yamashita","year":"2022","unstructured":"Yamashita H, Arakawa Y, Terada Y, Takeuchi Y, Mineharu Y, Sumiyoshi S, et al. Whole-genome sequencing analysis of an atypical teratoid\/rhabdoid tumor in a patient with Phelan-McDermid syndrome: a case report and systematic review. Brain Tumor Pathol. 2022;39:232\u20139.","journal-title":"Brain Tumor Pathol"},{"key":"1674_CR47","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<389::AID-MPO16>3.0.CO;2-H","volume":"32","author":"DN Korones","year":"1999","unstructured":"Korones DN, Meyers SP, Rubio A, Torres C, Constine LS. A 4-year-old girl with a ventriculoperitoneal shunt metastasis of a central nervous system atypical teratoid\/rhabdoid tumor. Med Pediatr Oncol. 1999;32:389\u201391.","journal-title":"Med Pediatr Oncol"},{"key":"1674_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3345\/kjp.2014.57.7.333","volume":"57","author":"EH Cho","year":"2014","unstructured":"Cho EH, Park JB, Kim JK. Atypical teratoid rhabdoid brain tumor in an infant with ring chromosome 22. Korean J Pediatr. 2014;57:333\u20136.","journal-title":"Korean J Pediatr"},{"key":"1674_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ajmg.a.37993","volume":"173","author":"HM Byers","year":"2017","unstructured":"Byers HM, Adam MP, LaCroix A, Leary SES, Cole B, Dobyns WB, et al. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22. Am J Med Genet A. 2017;173:245\u20139.","journal-title":"Am J Med Genet A"},{"key":"1674_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.741062","volume":"12","author":"M Crocco","year":"2021","unstructured":"Crocco M, Panciroli M, Milanaccio C, Morerio C, Verrico A, Garr\u00e8 ML, et al. Case Report: The Emerging Role of Ring Chromosome 22 in Phelan-McDermid Syndrome With Atypical Teratoid\/Rhabdoid Tumor: The First Child Treated With Growth Hormone. Front Neurol. 2021;12:741062.","journal-title":"Front Neurol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01674-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01674-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01674-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T21:04:40Z","timestamp":1732050280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01674-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1674"],"URL":"https:\/\/doi.org\/10.1038\/s41431-024-01674-z","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Research Ethics Board (REB#1000053261) at the Hospital for Sick Children (SickKids; Toronto, Canada).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}